Undervalued Small Caps With Insider Buying

Results

65

17 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

65 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	BMRC	US$28.29	-0.3%	24.7%	US$456.1m	US$31.80	1.1	102.5%	3.5%	Banks
	RCEL	US$7.85	1.0%	39.4%	US$247.7m	US$9.03	3.2	73.2%	n/a	Pharmaceuticals & Biotech
	CDNL New	US$39.42	-38.4%	n/a	US$1.6b	US$61.00	1.2	162.4%	n/a	Capital Goods
	KINS	US$19.69	3.5%	40.8%	US$281.9m	US$24.00	8.1	14.6%	1.2%	Insurance
	ENOV	US$26.06	-2.1%	-11.8%	US$1.5b	US$41.25	0.7	145.8%	n/a	Healthcare
	ONT	US$17.62	6.7%	-37.1%	US$614.6m	US$18.60	0.8	145.1%	n/a	Commercial Services
	AUBN	US$26.25	-0.4%	1.4%	US$92.3m	n/a	1.0	n/a	4.1%	Banks
	SHBI	US$23.97	0.5%	52.4%	US$798.9m	US$25.75	1.3	8.1%	2.3%	Banks
	BOTJ New	US$27.77	1.9%	96.1%	US$126.1m	n/a	1.5	n/a	1.4%	Banks
	ILPT	US$8.92	1.6%	54.1%	US$610.7m	US$11.17	1.3	20.7%	4.5%	Real Estate
	ORN	US$9.93	-3.7%	47.1%	US$392.0m	US$15.32	111.6	74.8%	n/a	Capital Goods
	UNB	US$24.59	4.4%	-9.9%	US$121.6m	n/a	1.3	n/a	5.9%	Banks
	SMWB	US$8.89	18.4%	5.1%	US$784.5m	US$10.80	2.7	117.0%	n/a	Software
	GABC	US$51.38	1.7%	30.6%	US$1.9b	US$56.20	1.6	5.6%	2.4%	Banks
	EMYB	US$22.44	-0.04%	40.9%	US$166.2m	n/a	1.3	n/a	2.1%	Banks
	ANIK	US$21.50	0.4%	143.5%	US$283.3m	US$21.00	2.4	112.3%	n/a	Pharmaceuticals & Biotech
	KRO	US$8.47	-1.4%	40.9%	US$995.6m	US$7.00	0.5	4.6%	2.4%	Materials
	TRIN New	US$18.14	0.5%	13.7%	US$1.7b	US$18.50	12.2	20.8%	11.2%	Diversified Financials
	CMTV	US$41.93	5.2%	82.5%	US$228.2m	n/a	1.9	n/a	2.4%	Banks
	FRST	US$16.66	2.5%	50.2%	US$412.3m	US$19.19	0.9	-2.9%	2.4%	Banks
	ICCC New	US$10.05	-8.6%	64.7%	US$98.6m	n/a	3.0	n/a	n/a	Pharmaceuticals & Biotech
	ALRS New	US$33.67	1.3%	55.9%	US$844.2m	US$35.40	30.4	40.6%	2.6%	Diversified Financials
	PMTS	US$28.50	2.8%	82.6%	US$334.4m	US$32.50	23.9	46.8%	0%	Tech
	HPP New	US$13.90	-3.2%	-26.2%	US$803.5m	US$16.75	0.3	62.0%	0%	Real Estate

Page 1 of 2